Health news
The New Drug Application (NDA) for landiolol has been submitted to the Food and Drug Administration (FDA) for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter.…
An increased risk for dementia has been reported among patients with atrial fibrillation (AF) associated with diabetes and stroke, according to study findings published in The American Journal of Cardiology. AF is associated with dementia…
A survey found that firefighters may be at higher risk for atrial fibrillation (AF) as the number of fires they fight per year increases. These findings were published in the Journal of the American Heart…
Atrial fibrillation (AF) affects up to 6.1 million individuals in the United States, and the Centers for Disease Control and Prevention anticipates that this number will reach 12.1 million by the year 2030.1,2 These estimates…
A contact-free optical device may be effective for detecting atrial fibrillation, according to research presented at the American College of Cardiology 71st Annual Scientific Session & Expo, from April 2nd through 4th, in Washington, DC.…
Patients with obstructive sleep apnea (OSA) who receive transcatheter aortic valve replacement (TAVR) have a higher risk for atrial fibrillation (AF), cardiac arrest, stroke, and redo-TAVR or redo-surgical aortic valve replacement (SAVR) compared with those…
Moderate physical activity was found to reduce risk for atrial fibrillation (AF) events, according to a study published in Open Heart. The Tromsø Study was a single-center, population-based cohort study conducted in Norway between 1994…
Racial and ethnic disparities in anticoagulation initiation for atrial fibrillation (AF) exist among patients dually enrolled in Medicare and the Veterans Health Administration (VHA), Department of Veterans Affairs (VA), according to study findingspresented at the…
The following article is a part of conference coverage from the American Heart Association Scientific Sessions 2021, being held virtually from November 13 to 15, 2021. The team at Cardiology Advisor will be reporting on…
Since their first approval, nonvitamin K antagonist oral anticoagulants (NOACs; also known as direct oral anticoagulants or DOACs) have become a common treatment for stroke prophylaxis in patients with nonvalvular atrial fibrillation (NVAF).1 Current US…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021